Holen Sie sich die Stockscreener-App
1.81
4.62%
0.0799
Bionexus Gene Lab Corp Aktie (BGLC) Neueste Nachrichten
Price to sales forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Enterprise value to revenue forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Number of shareholders of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Enterprise value to EBITDA forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Company Profile & Introduction - Moomoo
Price to earnings forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Price to book forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
BioNexus Gene Lab Corp (BGLC) Slips 6.95% as Shares Test Key Support LevelsGEX Level - Město Břeclav
BioNexus Gene Lab Corp (BGLC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BioNexus Gene Lab Corp (BGLC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BioNexus Gene Lab Corp (BGLC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BioNexus Gene Lab Corp (BGLC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BioNexus Gene Lab Corp (BGLC) Institutional Confidence - TradingKey
BioNexus Gene Lab Corp (BGLC) Valuation: PE, PB & Fair Value Analysis - TradingKey
BioNexus Gene Lab Corp (BGLC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BioNexus Gene Lab Corp (BGLC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioNexus Gene Lab Corp (BGLC) Edges Higher as Shares Hold Above Key Support at $2.47Channel Breakout - newsline.com
12 Industrials Stocks Moving In Thursday's Pre-Market Session - Benzinga
BioNexus Gene Lab Corp (BGLC) Slips 4.1%: Testing Key Support at $2.09Elliott Wave Entry - newsline.com
BioNexus Gene Lab Calls for Malaysia–China Biotech Co-Development and Precision Healthcare Collaboration 1 - Minichart
BioNexus Gene Lab Urges Malaysia–China Co-Development of Biotech Platforms After Kuala Lumpur Forum - TradingView
BioNexus Gene Lab (Nasdaq: BGLC) pushes Malaysia–China biotech co-development model - Stock Titan
BioNexus Gene Lab Corp (BGLC) Declines 8.33% as Stock Approaches Key SupportHigh Beta Stocks - The Legal Advocate
BioNexus Gene Lab Corp (BGLC) Slides 4.17% as Support Level Nears – Key Levels to WatchRating Change - newsline.com
BioNexus Gene Lab Corp (BGLC) Slides 6.25%: Key Support Zone Under ScrutinyCash Flow Strong Stocks - The Legal Advocate
BioNexus Gene Lab Corp. Calls for Malaysia-China Biotechnology Collaboration Focused on Joint Development - geneonline.com
BioNexus Gene Lab Corp. Calls for Malaysia–China - GlobeNewswire
Turning Malaysia into a bridge for China’s biotech ambitions - Stock Titan
BioNexus Gene Lab Corp (BGLC) Slips 3.33% as Stock Tests Key Support at $2.20Long Term Entry Picks - dars.gov.et
BGLCBioNexus Gene Lab Corp Stock Price and Quote - Finviz
BioNexus Gene Lab Stock Edges Up While Nasdaq Microcap Faces Chemrex Cash Battle - Bez Kabli
12 Industrials Stocks Moving In Wednesday's After-Market Session - Sahm
BioNexus Gene Lab Corp (BGLC) Surges 8.44%: Testing Key Resistance at $2.30Channel Breakout - The Legal Advocate
BioNexus Gene Lab (BGLC) Extends Decline, Tests Key Support at $1.92Crowd Entry Signals - Newser
BioNexus Gene Lab Corp 1Q 2026: Revenue $22.84K, EPS ($0.23) — 10-Q Summary - TradingView
BioNexus Gene Lab Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[10-Q] BioNexus Gene Lab Corp Quarterly Earnings Report - Stock Titan
BGLC | BioNexus Gene Lab Corp Insider Trading - Quiver Quantitative
TradingKey - TradingKey
Is BioNexus Lab (BGLC) stock fading in strength |Community Buy Alerts - newser.com
BioNexus Lab (BGLC) Risk Reward Ratio | BioNexus Gene Lab posts strong revenue, net lossCertified Trade Ideas - Xã Vĩnh Công
BioNexus Gene Lab: Chemical Raw Materials & Genomic Screening Business Overview, Growth Strategies, and Market Insights 19233034 - Minichart
BioNexus Gene Lab 10-K: Revenue $7.42M, EPS $(1.61) - TradingView
[10-K] BioNexus Gene Lab Corp Files Annual Report - Stock Titan
BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Analyst Upgrade: Will BioNexus Gene Lab Corp stock recover after earningsPortfolio Profit Report & Precise Entry and Exit Recommendations - baoquankhu1.vn
BioNexus Gene Lab Corp. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Will BioNexus Lab (BGLC) Stock Grow in 2026 | Price at $2.15, Down 4.41%Put Support - newsline.com
Ideas Watch: Does BioNexus Gene Lab Corp stock reflect fundamentalsShare Buyback & Entry Point Strategy Guides - baoquankhu1.vn
BGLC Stock Price, Quote & Chart | BIONEXUS GENE LAB CORP (NASDAQ:BGLC) - ChartMill
How is BioNexus Lab (BGLC) Stock performing in 2026 | Price at $2.30, Up 1.71%Weak Sell Signals - The Legal Advocate
Can BioNexus Lab (BGLC) Stock Go Higher | Price at $2.23, Up 0.98%Bollinger Expansion - newsline.com
BGLC SEC FilingsBionexus Gene La 10-K, 10-Q, 8-K Forms - Stock Titan
[NT 10-K] BioNexus Gene Lab Corp SEC Filing - Stock Titan
12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Benzinga
1.85%
1.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):